Please assess the completion status of the following clinical trial:

Trial Title: Effects of Aquamin F on Osteoarthritis of the Knee

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1/PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria~* Subjects aged 35 to 75, male or female~* Subjects diagnosed with symptomatic moderate to severe osteoarthritis of the knee according to the modified criteria of the American College of Rheumatology17, 18~* Subjects who present with osteoarthritis of the knee as judged by symptoms and disabilities detectable through published, validated questionnaires or previous diagnosis by a physician.~* Subjects who are symptomatic with daily or near daily pain and stiffness from osteoarthritis.~* Subjects with screening WOMAC Osteoarthritis Index total score (transformed score) of not more than 75.~* Subjects with ability to comprehend and complete the questionnaires and forms.~* Subjects whose schedules permit clinic evaluations every four weeks.~* Subjects who are willing to stop taking calcium supplements, if any, and to restrict consumption of high calcium foods to 600 mg (two dairy serving) per day~* Subjects with a high probability of compliance with study procedures and test article consumption.~* Subjects willing and able to follow protocol guidelines and schedules, and complete diaries.~* Subjects who are likely to abstain from taking unauthorized supplements or participating in any other clinical trial or experimental treatment during this trial~* Subjects with normal gastrointestinal digestion and absorption.~Exclusion Criteria~* Subjects suffering from inflammatory arthritis, gout, pseudogout, Paget's disease, seizure disorder, insulin dependent diabetes mellitus, uncontrolled hypertension, unstable cardiovascular disease, active hepatic or renal disease, active cancer and/or HIV infection.~* Subjects who are non-ambulatory or bedridden due to osteoarthritis.~* Subjects who are dependent on prescription drugs to control pain.~* Subjects on any other clinical trial or experimental treatment in the past 3 months~* Subjects who are pregnant, lactating, or at risk of becoming pregnant.~* Subjects who have received:~  * Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) within 48 hours prior to study enrollment.~ * Intramuscular or systemic corticosteroid injection within 4 weeks prior to study enrollment.~ * Intra-articular corticosteroid injection within 2 months prior to study enrollment.~ * Intra-articular hyaluronic acid injection within 4 months prior to study enrollment.

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).